Target Price | $55.64 |
Price | $21.68 |
Potential |
156.63%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target AnaptysBio, Inc. 2025 .
The average AnaptysBio, Inc. target price is $55.64.
This is
156.63%
register free of charge
$90.00
315.13%
register free of charge
$30.00
38.38%
register free of charge
|
|
A rating was issued by 12 analysts: 10 Analysts recommend AnaptysBio, Inc. to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the AnaptysBio, Inc. stock has an average upside potential 2025 of
156.63%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 17.16 | 33.91 |
66.76% | 97.63% | |
EBITDA Margin | -901.52% | -479.83% |
17.78% | 46.78% | |
Net Margin | -971.88% | -534.06% |
20.22% | 45.05% |
12 Analysts have issued a sales forecast AnaptysBio, Inc. 2024 . The average AnaptysBio, Inc. sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an AnaptysBio, Inc. EBITDA forecast 2024. The average AnaptysBio, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 AnaptysBio, Inc. Analysts have issued a net profit forecast 2024. The average AnaptysBio, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -6.08 | -6.60 |
33.04% | 8.55% | |
P/E | negative | |
EV/Sales | 20.14 |
12 Analysts have issued a AnaptysBio, Inc. forecast for earnings per share. The average AnaptysBio, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the AnaptysBio, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
AnaptysBio, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.